20 stocks of companies showing excellent earnings-season trends even as the economy coolsMarket Watch • 05/12/25
INCY Q1 Earnings & Revenues Beat Estimates on Higher Product SalesZacks Investment Research • 04/29/25
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical ProgramsBusiness Wire • 04/29/25
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025Business Wire • 04/25/25
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual MeetingBusiness Wire • 04/23/25
Incyte Gears Up to Report Q1 Earnings: Here's What You Should KnowZacks Investment Research • 04/23/25
Incyte's New Treatment for Chronic Skin Disease Shows Promising Results In Latest Clinical Trials, Stock FallsBenzinga • 03/17/25
Incyte Plummets 13% As Skin Disease Drug Looks 'Viable, But Not Competitive'Investors Business Daily • 03/17/25
Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients With Hidradenitis SuppurativaBusiness Wire • 03/17/25
Incyte (INCY) Up 2.6% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/12/25
INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis StudiesZacks Investment Research • 03/10/25